Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.6221 USD | +3.32% | +3.32% | -37.79% |
2023 | EV Biologics, Inc. Closes A $500,000 Interest-Free Loan | CI |
2023 | Ev Biologics Completes Production of Cutting-Edge Msc Exosome-Based Therapeutic | CI |
Financials (USD)
Sales 2016 | 42.64M | Sales 2017 | 9.51M | Capitalization | 6.09M |
---|---|---|---|---|---|
Net income 2016 | -53M | Net income 2017 | -7M | EV / Sales 2016 | 0.69 x |
Net Debt 2016 | 9M | Net Debt 2017 | 10.03M | EV / Sales 2017 | 1.7 x |
P/E ratio 2016 |
-0.38
x | P/E ratio 2017 |
-0.82
x | Employees | - |
Yield 2016 * |
-
| Yield 2017 |
-
| Free-Float | 23.58% |
1 day | +3.32% | ||
1 week | +3.32% | ||
Current month | -11.63% | ||
1 month | -11.63% | ||
3 months | -11.39% | ||
6 months | -58.53% | ||
Current year | -37.79% |
Managers | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
William Bossung
BRD | Director/Board Member | - | 23-08-06 |
Members of the board | Title | Age | Since |
---|---|---|---|
Daniel McKinney
CEO | Chief Executive Officer | 62 | 18-10-28 |
William Bossung
BRD | Director/Board Member | - | 18-12-02 |
Jason Sanders
BRD | Director/Board Member | 46 | 20-08-30 |
1st Jan change | Capi. | |
---|---|---|
-37.79% | 6.36M | |
+19.57% | 48.58B | |
-4.69% | 15.52B | |
+2.88% | 15.46B | |
-15.73% | 10.44B | |
+27.35% | 8.84B | |
+105.28% | 8.27B | |
+4.79% | 7.96B | |
-7.17% | 7.34B | |
+24.55% | 6.73B |
- Stock Market
- Equities
- YECO Stock